SMTL ID : 6slg.1

HUMAN ERK2 WITH ERK1/2 INHIBITOR, AZD0364.

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.33 Å

Oligo State

monomer

Ligands

1 x ALA- ALA- LEU- ALA- PHE: ERK-tide(Non-covalent)

ALA-ALA-LEU-ALA-PHE.1: 5 residues within 4Å: Chain A: D.143, H.144, Y.147, C.180, Y.335 4 PLIP interactions: 4 interactions with chain A Hydrophobic interactions: A:Y.147, A:Y.147, A:Y.147 Hydrogen bonds: A:D.143

1 x LHZ: (6~{R})-7-[[3,4-bis(fluoranyl)phenyl]methyl]-6-(methoxymethyl)-2-[5-methyl-2-[(2-methylpyrazol-3-yl)amino]pyrimidin-4-yl]-5,6-dihydroimidazo[1,2-a]pyrazin-8-one(Non-covalent)

LHZ.2: 21 residues within 4Å: Chain A: G.51, E.52, G.53, Y.55, G.56, M.57, V.58, A.71, K.73, Q.124, D.125, M.127, E.128, T.129, D.130, K.133, S.172, N.173, L.175, C.185, D.186 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:Y.55, A:K.73, A:L.175 Hydrogen bonds: A:K.73, A:M.127, A:M.127 Water bridges: A:T.129, A:D.186

2 x SO4: SULFATE ION(Non-functional Binders)

SO4.3: 5 residues within 4Å: Chain A: Y.206, R.210, R.213, H.251, Y.252 6 PLIP interactions: 6 interactions with chain A Water bridges: A:R.210, A:R.213, A:Y.252, A:Y.252 Salt bridges: A:R.210, A:R.213 SO4.4: 6 residues within 4Å: Chain A: G.201, F.202, N.276, L.277, K.278, A.279 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:F.202, A:N.276, A:K.278, A:A.279

4 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.5: 5 residues within 4Å: Chain A: L.260, S.265, L.286, P.287, K.289 No protein-ligand interaction detected (PLIP) EDO.6: 7 residues within 4Å: Chain A: R.96, F.97, Y.158, A.162, A.344, E.345, A.346 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:R.96, A:R.96, A:E.345, A:A.346 Water bridges: A:Y.158 EDO.7: 6 residues within 4Å: Chain A: R.110, A.111, Q.116, M.117, K.118, D.119 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:A.111, A:K.118, A:D.119 EDO.8: 3 residues within 4Å: Chain A: E.324, A.328, Y.336 No protein-ligand interaction detected (PLIP)

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Ward, R.A. et al., Discovery of a Potent and Selective Oral Inhibitor of ERK1/2 (AZD0364) That Is Efficacious in Both Monotherapy and Combination Therapy in Models of Nonsmall Cell Lung Cancer (NSCLC). J.Med.Chem. (2019)

Release Date

2019-11-20

Peptides

Mitogen-activated protein kinase 1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Mitogen-activated protein kinase 1

Related Entries With Identical Sequence